Periodontal inflammation in renal transplant recipients receiving Everolimus or tacrolimus - preliminary results

Oral Diseases

Volumn 19, Issue 7, 2013, Pages 666-672

  Pereira Lopes, O ^a,b   Sampaio Maia, B ^a,b   Sampaio, S ^b   Vieira Marques, P ^b   Monteiro da Silva, F ^a   Braga, Ac ^c   Felino, A ^a   Pestana, M ^b  

^a U Porto   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Calcineurin inhibitors; Everolimus; MTOR inhibitors; Oral health; Periodontal disease; Renal transplant recipients; Tacrolimus

Indexed keywords

EVEROLIMUS; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; ARTICLE; BLEEDING; BODY MASS; CROSS-SECTIONAL STUDY; DENTAL CARIES; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PERIODONTAL EXAMINATION; PERIODONTITIS; PH; PRIORITY JOURNAL; READING; RENAL TRANSPLANT RECIPIENT; SALIVATION; SMOKING HABIT; TOOTH PLAQUE; ADOLESCENT; AGE; ALLOGRAFT; ANALOGS AND DERIVATIVES; CLASSIFICATION; COMPARATIVE STUDY; GINGIVA BLEEDING; HEALTH; HEALTH STATUS; HEALTH SURVEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTICS; PHYSIOLOGY; SALIVA; SECRETION (PROCESS); SECRETION RATE; SMOKING; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLOGRAFTS; CROSS-SECTIONAL STUDIES; DENTAL PLAQUE INDEX; DMF INDEX; FEMALE; GINGIVAL HEMORRHAGE; HEALTH STATUS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORAL HEALTH; ORAL HYGIENE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTITIS; SALIVA; SECRETORY RATE; SIROLIMUS; SMOKING; TACROLIMUS; YOUNG ADULT;

EID: 84882613584     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12051     Document Type: Article

References (47)

1. Aas E (1963). Hyperplasia gingival diphenylhydantoin. Acta Odontol Scand 21: 1-142.
2. Al-Aradi A, Phelan PJ, OKelly P et al (2009). An assessment of the long-term health outcome of renal transplant recipients in Ireland. Ir J Med Sci 178: 407-412.
3. Amato RJ, Jaroslaw J, Giessinger S, Saxena S, Willis JP (2009). A Phase 2 Study With a Daily Regimen of the Oral mTOR Inhibitor RADOO1 (Everolimus) in Patients With Metastatic Clear Cell Renal Cell Cancer. Cancer 115: 2438-2446.
4. Armitage GC (2004). Periodontal diagnoses and classification of periodontal diseases. Periodontology 2000(34): 9-21.
5. Asikainen S, Dogan B, Turgut Z, Paster BJ, Bodur A, Oscarsson J (2010). Specified Species in Gingival Crevicular Fluid Predict Bacterial Diversity. PLoS ONE 5: e13589.
6. Attaphol P, Suneet S, Hans M et al (2007). Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. Cancer Chemother Pharmacol 60: 179-188.
7. Baogonekczkowska T, Durlik M (2009). Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients. Pol Arch Med Wewn 11: 9.
8. Barendregt DS, Van dVU, Timmerman MF, Van dWG (2006). Comparison of two automated periodontal probes and two probes with a conventional readout in periodontal maintenance patients. J Clin Periodontol 33: 276-282.
9. Björn N (2004). Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors. Transpl Int 17: 279-285.
10. Bogren A, Teles R, Torresyap G et al (2007). A three-year prospective study of adult subjects with gingivitis I: clinical periodontal parameters. J Clin Periodontol 34: 1-6.
11. Castillo A, Mesa F, Liébana J et al (2007). Periodontal and oral microbiological status of an adult population undergoing haemodialysis: cross-sectional study. Oral Dis 13: 198-205.
12. Chu FC, Tsang PC, Chan AW, Leung WK, Samaranayake LP, Chan TM (2000). Oral health status, oral microflora, and non-surgical periodontal treatment of renal transplant patients receiving cyclosporin A and FK506. Ann R Australas Coll Dent Surg 15: 286-291.
13. Civarella D, Guiglia R, Campisi G et al (2007). Update on gingival overgrowth by cyclosporine A in renal transplants. Med Oral Patol Oral Cir Bucal 12: E19-E25.
14. De Almeida PDV, Grégio AMT, Machado MÂN, de LA, Azevedo LR (2008). Saliva Composition and Functions: A Comprehensive Review. J Contemp Dent Pract 9: 17-80.
15. Demmer RT, Desvarieux M (2006). Periodontal infections and cardiovascular disease The heart of the matter. J Am Dent Assoc 13: 7.
16. Deo V, Bhongade ML (2010). Pathogenesis of periodontitis: role of cytokines in host response. Dent Today 29: 60-62.
17. Ferreira-Filho SR, Cardoso CC, Castro LAV, Oliveira RM, Sá RR (2011). Comparison of Measured Creatinine Clearance and Clearances Estimated by Cockcroft-Gault andMDRD Formulas in Patients with a Single Kidney. Int J Nephrol 201: 1.
18. Flechner SM (2007). Cancer and renal transplantation. ASiM 7: 411-419.
19. Gibbs CH, Hirschfeld JW, Lee JG et al (1988). Description and clinical evaluation of a new computerized periodontal probe-the Florida probe. J Clin Periodontol 15: 137-144.
20. Greenberg KV, Armitage GC, Shiboski CH (2008). Gingival enlargement among renal transplant recipients in the era of new-generation immunosuppressants. J Periodontol 79: 453-460.
21. Guba M, Graeb C, Karl-Walter J, Geissler EK (2004). Pro- and anti-cancer effects of immunosupressive agents used in organ transplantation. Transplantation 77: 1777-1782.
22. Hernández G, Arriba L, Lucas M, de AA (2000). Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol 71: 1630-1636.
23. Horowitz AM, Kleinman DV (2008). Oral health literacy: the new imperative to better oral health. Dent Clin North Am 52: 333-344.
24. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD (1997). The codependence of angiogenesis and chronic inflammation. FASEB J 11: 457-465.
25. James JA, Jamal S, Hull PS et al (2001). Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol 28: 848-852.
26. Klaus H, Rateitschark EM, Wolf H, Hassel TM (1985). Color Atlas of Periodontology, Georg Thieme Verlag Stuttgart: New York.
27. Lagerlof F, Oliveby A (1994). Caries-protective factors in saliva. Adv Dent Res 8: 229-238.
28. Lebranchu Y, Thierry A, Toupance O et al (2009). Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study. Am J Transplant 9: 1115-1123.
29. Lindhe J, Karring T, Lang NP (2003). Clinical Periodontology and Implant Dentistry. 4th edn. Blachwell Munksgaard: Oxford, UK.
30. Little JW, Falace DA, Miller CS, Rhodus NL (2008). Dental management of the medically compromised patient. 7th edn. Mosby Elsevier: Missouri, p. 627.
31. Löe H (1967). The gingival index, the plaque index, and the retention index systems. J Periodontol 38: 610-616.
32. Löe H, Silness J (1963). Periodontal disease in pregnancy Prevalence and severity. Acta Odontol Scand 21: 533-551.
33. McKaig SJ, Kelly D, Shaw L (2002). Investigation of the effect of FK506 (tacrolimus) and cyclosporin on gingival overgrowth following paediatric liver transplantation. Int J Paediatr Dent 12: 398-403.
34. Molony DA, Craig JC (2009). Evidence-based nephrology. 1st edn. Blackwell Publishing Ltd: Oxford.
35. Nesse W, Abbas F, Ploeg IVD et al (2008). Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 35: 668-673.
36. Nibali L, D′Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS (2007). Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 34: 931-937.
37. Pink R, Simek J, Vondrakova J et al (2009). Saliva as a Diagnostic Medium. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 153: 103-110.
38. Schroede HE, Listgarten RMA (1997). The gingival tissues: the architecture of periodontal protection. Periodontology 2000(13): 91-120.
39. Sekiguchi RT, Paixão CG, Saraiva L, Romito GA, Pannuti CM, Lotufo RFM (2007). Incidence of tacrolimus-induced gengival overgrowth in the absence of calcium channel blockers: a short-term study. J Clin Periodontol 34: 545-550.
40. Silva HT, Cibrik D, Johnston T et al (2010). Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients. Am J Transplant 10: 1401-1413.
41. Smith QT, Hamilton MJ (1981). Salivary composition, phenytoin ingestion and gingival overgrowth. J Periodontol 52: 673-679.
42. Spolidorio LC, Spolidorio DMP, Massucato EMS, Neppelenbroek KH, Campanha NH, Sanches MH (2006). Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral Dis 12: 309-314.
43. Summers SA, Tilakaratne WM, Fortune F, Ashman N (2007). Renal disease and the mouth. Am J Med 120: 568-573.
44. Ulricha C, Kanitakisb J, Stockfletha E, Euvrardb S (2008). Skin Cancer in Organ Transplant Recipients-Where Do We Stand Today? Am J Transplant 8: 2192-2198.
45. WHO (1997). Oral health survey: basic methods. In: Organization WH, ed. 4 edn. WHO Library Cataloguing in Publication Data: Geneva, pp. 39-46.
46. Wynn RL, Meiller TF, Crossley HL (2002). Drug Information Handbook for Dentistry. Oral Medicine for Medically-Compromised Patients & Specific Oral Conditions. 8th edn. Lexi-Comp: Hudson, Ohio.
47. Zhou Y, Lin HC, Lo ECM, Wong MCM (2011). Risk indicators for early childhood caries in 2-year-old children in southern China. Aust Dent J 56: 33-39.